Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
ProstaPlant Urology System Ltd. |
---|---|
Information provided by: | ProstaPlant Urology System Ltd. |
ClinicalTrials.gov Identifier: | NCT00468026 |
The purpose of this ex-vivo study is to evaluate the insertion procedure for the ProstaPlant implant in human prostates and the support that it supplies to the prostate.
Condition | Intervention | Phase |
---|---|---|
Benign Prostatic Hyperplasia |
Device: ProstaPlant Stent |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jack Baniel, Prof. | 972-3-9376563 |
Israel | |
"Asuta" Medical Center | |
Tel-Aviv, Israel, 62748 |
Principal Investigator: | Jack Baniel, Prof. | "Rabin" Medical Center - "Belinson" Campus - Urology Department |
Study ID Numbers: | Human Ex-Vivo - V001-3.2007 |
Study First Received: | April 30, 2007 |
Last Updated: | April 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00468026 History of Changes |
Health Authority: | Israel: Ministry of Health |
BPH Prostate Stent Benign prostatic hyperplasia (BPH) |
Hyperplasia Prostatic Diseases Prostatic Hyperplasia Genital Diseases, Male |
Hyperplasia Pathologic Processes Prostatic Diseases Prostatic Hyperplasia Genital Diseases, Male |